Nanologica
1.04
SEK
-5.88 %
Less than 1K followers
NICA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-5.88%
-15.45%
-44.09%
-42.86%
-38.82%
-83.17%
-92.62%
-91.12%
-94.27%
Nanologica is a life science tools company that develops, manufactures and sells advanced consumables to pharmaceutical companies. Nanologica's silica-based products are specially designed for the purification of peptide drugs, such as insulin and GLP-1 analogs. Nanologica operates in a global niche market for medicines for the treatment of diabetes and obesity. Nanologica was founded in 2004 and has its headquarters in Södertälje.
Read moreMarket cap
91.9M SEK
Turnover
172.34K SEK
Revenue
14.54M
EBIT %
-407.57 %
P/E
-
Dividend yield-%
-
Financial calendar
10/7
2025
Interim report Q2'25
23/10
2025
Interim report Q3'25
6/2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Nanologica AB (publ) Announces the Outcome of the Exercise of Warrants of Series TO5
Kommentar från styrelsen i Nanologica AB (publ) angående budpliktsbud från Flerie Invest AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools